David J. Vaughn

Oncology

3400 Civic Center Boulevard
West Pavilion, 2nd Floor
Philadelphia, PA 19104

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 115 publications

Association of Y-chromosomal gr/gr deletions with testicular germ cell tumor: whole-genome analysis of 198,306 individuals.

Association of Y-chromosomal gr/gr deletions with testicular germ cell tumor: whole-genome analysis of 198,306 individuals.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Renal Impairment and Late Toxicities Comparing Contemporary Chemotherapy Regimens for Testicular Cancer in a Real-World Setting.

Renal Impairment and Late Toxicities Comparing Contemporary Chemotherapy Regimens for Testicular Cancer in a Real-World Setting.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: June 19, 2025

Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer Survivors.

Impact of Population Pharmacogenomics on Cisplatin-Induced Neurotoxicities in Testicular Cancer Survivors.

Journal: Cancer medicine

Published: May 29, 2025

The impact of telemedicine on racial and ethnic disparities in oncologic care during the COVID-19 pandemic.

The impact of telemedicine on racial and ethnic disparities in oncologic care during the COVID-19 pandemic.

Journal: American journal of cancer research

Published: January 21, 2025

Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancer.

Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancer.

Journal: Journal of the National Cancer Institute

Published: August 07, 2024

Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association study.

Identification of genes associated with testicular germ cell tumor susceptibility through a transcriptome-wide association study.

Journal: American journal of human genetics

Published: August 05, 2024

Cognitive function in long-term testicular cancer survivors: impact of modifiable factors.

Cognitive function in long-term testicular cancer survivors: impact of modifiable factors.

Journal: JNCI cancer spectrum

Published: May 02, 2024

Coronary Microvascular Dysfunction in Men with Prostate Cancer Receiving Androgen-Deprivation Therapy.

Coronary Microvascular Dysfunction in Men with Prostate Cancer Receiving Androgen-Deprivation Therapy.

Journal: Clinical genitourinary cancer

Published: February 26, 2024

Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.

Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 07, 2024

Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured on 18F-DCFPyL PET/CT.

Prostate Cancer Recurrence: Examining the Role of Salvage Radiotherapy Field and Risk Factors for Regional Disease Recurrence Captured on 18F-DCFPyL PET/CT.

Journal: Clinical genitourinary cancer

Published: January 11, 2024

Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer.

Social Determinants of Health Mediate Racial Disparities in Cardiovascular Disease in Men With Prostate Cancer.

Journal: JACC. CardioOncology

Published: January 08, 2024

Impact of Prior Chemotherapy on Response to Second-line Pembrolizumab in Urothelial Cancer: Exploratory Analysis of the Phase 3 KEYNOTE-045 Trial.

Impact of Prior Chemotherapy on Response to Second-line Pembrolizumab in Urothelial Cancer: Exploratory Analysis of the Phase 3 KEYNOTE-045 Trial.

Journal: European urology

Published: December 21, 2023

Showing 1-12 of 115

Last Updated: 09/26/2026